Bringing circulating tumor DNA to the clinic in Hodgkin lymphoma

Haematologica. 2021 Jan 1;106(1):5-6. doi: 10.3324/haematol.2020.265165.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Biomarkers, Tumor
  • Circulating Tumor DNA* / genetics
  • Genotype
  • Hodgkin Disease* / diagnosis
  • Hodgkin Disease* / genetics
  • Humans
  • Prospective Studies

Substances

  • Biomarkers, Tumor
  • Circulating Tumor DNA